A multicenter, randomized, parallel-group, placebo-controlled, efficacy and safety trial to evaluate the effect of SCH 497079 on weight in obese and overweight subjects.
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2018
At a glance
- Drugs SCH 497079 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Jul 2008 The expected completion date for this trial is now 1 Jan 2009 (information from ClinicalTrials.gov)